XXII 외환 뉴스
22nd Century Group Initiates Process To Evaluate Strategic Alternatives For Its Tobacco Portfolio
Agricultural biotechnology company 22nd Century Group, Inc. (XXII) announced Tuesday that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company's tobacco assets.
RTTNews
|
436 일 전
22nd Century Group Names Hugh Kinsman As CFO
Agricultural biotechnology firm 22nd Century Group Inc. (XXII) announced Thursday the appointment of Hugh Kinsman as Chief Financial Officer. Kinsman is currently CFO of GVB Biopharma, which 22nd Century acquired effective May 13, 2022.
RTTNews
|
882 일 전
